Radiation therapy for mouth cancer works by using high-energy X-rays to kill cancer cells. MSK offers precise radiation ...

Head and neck cancer is a broad term for several types of cancers that include the mouth (oral cavity), throat (pharynx), voice box (larynx), sinuses and nose cavity, and salivary glands. Head and ...

When are protons are typically preferred in treating head and neck cancers? While there are general principles, the decision to treat head and neck cancers with proton radiation at Fred Hutch Cancer ...

Radiation therapy works by using high-energy X-rays to kill cancer cells. MSK offers precise radiation therapy that kills throat cancer cells with fewer side effects from radiatio ...

In definitive radiotherapy, reducing the elective dose from 50 Gy to 43 Gy was safe and did not significantly increase the risk for recurrence in electively irradiated lymph nodes among patients with ...

A small prospective study from Taiwan showed that olfactory function begins to deteriorate at a radiation therapy dose of 22 Gy in patients with head and neck cancer. Only 17% of patients developed ...

Oral stents have emerged as a valuable adjunct in the radiotherapy of head and neck cancer, allowing clinicians to displace and immobilise non-target tissues, thereby reducing radiation exposure to ...

SHREVEPORT, La. - A new landmark study published in The Lancet is changing how doctors treat certain head and neck cancers. One of the researchers involved, radiation oncologist Dr. Sanford Katz, ...

Photobiomodulation therapy significantly reduced severe oral mucositis and PEG tube placements in head and neck cancer patients undergoing radiotherapy. Patient-reported outcomes showed less mouth and ...

In more recent decades, HPV has been shown as a risk factor for developing head and neck cancer. Head and neck cancer covers everything from throat, tongue, and tonsil cancer to laryngeal, mouth, and ...

Tonsil cancer is the most common form of oropharyngeal (throat) cancer. But among all types of cancer, tonsil cancer is still relatively rare, affecting a little more than eight out of 100,000 people.